Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2007-06-05

FDA Approved: BACTRIM — Supplemental Application (Sun Pharmaceutical Industries, Inc)

View source ↗

Summary

FDA approved a supplemental application for BACTRIM (sulfamethoxazole and trimethoprim) to modify the labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACTRIM (Sulfamethoxazole and Trimethoprim)

Snippet

SUPPL AP for BACTRIM (SULFAMETHOXAZOLE AND TRIMETHOPRIM)